Taken together, these data obtained in a large series of BL and DLBCL indicate that positivity for EBI3 in tumoral cells strongly argues against a diagnosis of BL, while it is in favor of a DLBCL diagnosis. The gene discussed is EBI3; the disease is diffuse large B-cell lymphoma.